Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |